Brawn Biotech Limited (BOM:530207)

India flag India · Delayed Price · Currency is INR
22.00
+0.57 (2.66%)
At close: Jan 22, 2026
6.02%
Market Cap66.01M
Revenue (ttm)168.03M
Net Income (ttm)-5.61M
Shares Out3.00M
EPS (ttm)-2.02
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume416
Average Volume736
Open20.50
Previous Close21.43
Day's Range20.50 - 22.00
52-Week Range15.46 - 24.37
Beta0.15
RSI52.18
Earnings DateFeb 11, 2026

About Brawn Biotech

Brawn Biotech Limited engages in the trading of pharmaceutical products in India. It provides pharmaceutical formulations, including antibacterial, cardiovascular, antidiabetic, analgesic, gastrointestinal, antifungal, skin care, antipsychotic, antiasthmatic, antacid, antimalarial, and nutritional products. The company was formerly known as Brawn Pharmaceuticals Limited and changed its name to Brawn Biotech Limited in November 2010. The company was incorporated in 1985 and is based in New Delhi, India. [Read more]

Industry Pharmaceutical Preparations
Founded 1985
Employees 9
Stock Exchange Bombay Stock Exchange
Ticker Symbol 530207
Full Company Profile

Financial Performance

In 2024, Brawn Biotech's revenue was 134.75 million, a decrease of -18.30% compared to the previous year's 164.95 million. Losses were -17.40 million, 39.5% more than in 2023.

Financial Statements